Shift to HD Drives Strong Growth in Chinese Market for Endoscopes
Shanghai, China – 15th February - Expanding its dedicated research on the Chinese healthcare market, a new report from InMedica (www.in-medica.com), “The Chinese Market for Endoscopes - 2011 Edition”, highlights the growing acceptance of endoscopy in this geographic region.
With less twenty suppliers in the total Chinese endoscopy market, multinational companies are dominating the high-end of this market with advanced technologies and high average selling prices; their main customers are level 3 hospitals in China’s big cities. Consequently supply to the market is consolidated. However, local suppliers are competing in the low-end segment of the market; their main customers are level 2 and ‘other’ hospitals in the economically weaker regions of China.
Commented Owen Tang, Market Analyst at InMedica, “both HD and SD endoscopes will be widely used by Chinese hospitals over the coming years. Many clinical applications are understood and accepted by both hospitals and patients. We believe that with increased healthcare expenditure, patients will better understand their medical needs and requirements, and minimally invasive surgery will grow strongly in China, positively influencing the market for endoscopes”.
The impact of the reform on the endoscopes market is not as strong as many had expected, as the Chinese Government is prioritising basic healthcare services and endoscopes are not included. The annual growth rate for the Chinese market for endoscopes is forecast to remain fairly consistent over the next five years, even after the current healthcare reform policy comes to an end in 2011. In fact, total unit shipments into China are forecast to exceed 14,000 by 2015, representing a CAGR of 16.0%. Moreover, HD endoscopes are believed to be accepted by more level 3 hospitals and their sales will grow with a CAGR of more than 20%.
IHS Media Relations
About IHS Inc. (www.ihs.com)
IHS (NYSE: IHS) is the leading source of information, insight and analytics in critical areas that shape today’s business landscape. Businesses and governments in more than 165 countries around the globe rely on the comprehensive content, expert independent analysis and flexible delivery methods of IHS to make high-impact decisions and develop strategies with speed and confidence. IHS has been in business since 1959 and became a publicly traded company on the New York Stock Exchange in 2005. Headquartered in Englewood, Colorado, USA, IHS is committed to sustainable, profitable growth and employs more than 6,000 people in 31 countries around the world.
IHS is a registered trademark of IHS Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013 IHS Inc. All rights reserved.